ALNY
Alnylam Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
6.99 / 10
Outperform
Fund‑flow score is 7.73 (good), showing overall positive inflows, especially from block and extra‑large investors, while medium and large segments turn negative. Sentiment rating is Outperform. Analyst coverage is limited to one neutral Jefferies rating with a 100% historical win rate, indicating cautious optimism.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
0%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-16
InstitutionJefferies
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of ALNY?
- ALNY holds a Bullish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 6.99/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
